Agenus Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AGEN Nasdaq 2830 www.agenusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agenus Inc.

AGEN Early Access Revenues Signal a New Path Ahead of Approval - Jun 5th, 2026 12:01 pm
Is Agenus Stock a Hold Amid Valuation and Funding Risks? - Jun 5th, 2026 11:59 am
AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC - Jun 5th, 2026 11:54 am
Agenus Announces Virtual 2026 Annual Shareholders Meeting - Jun 2nd, 2026 2:30 pm
IBRX Stock Outlook After Q1 Results and a New FDA Review - May 29th, 2026 11:25 am
ImmunityBio: Anktiva Explained and What Comes Next - May 29th, 2026 11:21 am
AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential? - May 28th, 2026 8:49 am
How Agenus' Pipeline Progress Unlock Its Next Growth Phase - May 26th, 2026 10:31 am
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC - May 21st, 2026 3:00 pm
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026 - May 21st, 2026 3:00 pm
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer - May 15th, 2026 2:11 pm
Agenus (AGEN) Q1 Earnings and Revenues Miss Estimates - May 11th, 2026 6:05 pm
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus - May 11th, 2026 9:50 am
Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development - May 11th, 2026 6:45 am
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings - May 8th, 2026 11:17 am
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China - May 7th, 2026 11:37 am
ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down - May 7th, 2026 11:35 am
TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View - May 7th, 2026 10:08 am
Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised - May 7th, 2026 10:04 am
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates - May 6th, 2026 4:30 pm